← Leaderboards
Katey Rayner
New York University School Of Medicine
$948,356
Attributed
$1,896,711
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $487.2K · FY2015–18$500K$375K$250K$125K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$1,896,711 · 1
By mechanism
R01$1,896,711 · 1
Top collaborators
- Kathryn J Moore4 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- M Mahmood Hussain$20,347,941
- Ira Jay Goldberg$42,989,404
- Ute Frevert$4,521,572
- Allison B Reiss$1,032,144
- Moriya Tsuji$11,242,468
Others in their field
Top investigators on “Equilibrium”
- Praduman Jain · Vignet, Inc.$102,576,382
- Deborah T Hung · Massachusetts General Hospital$33,879,357
- Gregory S Martin · Emory University$33,572,074
- Wilbur A Lam · Emory University$33,572,074
- Fang Li · University Of Minnesota$33,215,604
- Reuben S Harris · University Of Texas Hlth Science Center$33,215,604
Research focus
EquilibriumExcretory FunctionApolipoprotein A-IAdipose TissueEventAtheroprotectiveAtherosclerosisAtp Binding Cassette Transporter 1AutophagocytosisAnimal ModelAnimalsBiogenesisBiologyCardiovascular DiseasesCholesterolClinical ResearchCoronary ArteriosclerosisDependenceDesignDiabeticDisorder RiskDoseArterial Fatty StreakFatty Acid Oxidation
Grant awards (4)
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2018 · HL
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2017 · HL
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2016 · HL
miR-33 Pathway Inhibition for Improving HDL Functionality$487,209
R01 · FY2015 · HL